Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference

Go back to Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference
(NYSE: OGN) Delayed: 13.75 -0.01 (0.07%)
Previous Close $13.76    52 Week High $8.00 
Open $13.75    52 Week Low $8.00 
Day High $13.77    P/E N/A 
Day Low $13.74    EPS $0.00 
Volume 2,555,624